| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 2,719,000 | 2,658,000 | 2,455,000 | 2,761,000 | | Cost of Revenue | 1,259,000 | 3,410,000 | 1,281,000 | 2,703,000 | | | Gross Profit | 1,460,000 | (752,000) | 1,174,000 | 58,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 1,380,000 | (914,000) | 1,106,000 | 292,000 | | Non Recurring | 15,000 | (26,000) | 33,000 | 89,000 | | Others | 59,000 | 66,000 | 60,000 | 56,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 6,000 | 122,000 | (25,000) | (379,000) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (5,000) | 13,000 | (7,000) | 30,000 | | Earnings Before Interest And Taxes | 1,000 | 135,000 | (32,000) | (349,000) | | Interest Expense | 81,000 | 77,000 | 71,000 | 196,000 | | Income Before Tax | (80,000) | 58,000 | (103,000) | (545,000) | | Income Tax Expense |
-
|
-
|
-
| (3,000) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (80,000) | 58,000 | (103,000) | (542,000) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (80,000) | 58,000 | (103,000) | (542,000) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($80,000) | $58,000 | ($103,000) | ($542,000) |
|
0.28% Nasdaq 
0.08 (1.66%) 
Income Statement
